TY - JOUR
T1 - Biological variations of seven tumor markers
AU - Qi, Zhihong
AU - Zhang, Lin
AU - Chen, Yu
AU - Ma, Xinming
AU - Gao, Xuehui
AU - Du, Juan
AU - Zhang, Fang
AU - Cheng, Xinqi
AU - Cui, Wei
N1 - Funding Information:
This work was supported by the National Natural Science Foundation of China (The grant numbers are 81472029 and 81071418 ).
Publisher Copyright:
© 2015.
PY - 2015/10/23
Y1 - 2015/10/23
N2 - Background: We sought to identify biological variations in the following tumor markers: pepsinogen I (PGI), pepsinogen II (PGII), carbohydrate antigen 724 (CA724), neuron-specific enolase (NSE), pro-gastrin-releasing peptide (ProGRP), carcinoembryonic antigen (CEA), and carbohydrate antigen 199 (CA199). Methods: Serum samples were collected from 20 healthy Chinese individuals over 5days. Samples were then screened for the presence of the seven aforementioned tumor markers. Within-individual coefficient of variation (CVI), between-individual coefficient of variation (CVG), confidence interval (CI) of biological variations, index of individuality (II), and the reference change value (RCV) of the seven tumor markers were calculated. Results: Of the 7 tumor markers, index of individuality was all <1.0. ProGRP showed the lowest CVI and CVG, at 4.75% (CI: 3.96%-5.94%) and 16.42% (CI: 12.32%-24.61%), respectively. The 95% and 99% RCVs for ProGRP were 14.68 and 19.32, respectively, and were the lowest of the markers. In contrast, the CVI and CVG for CA724 were the highest, at 16.06% (CI: 13.83%-19.17%) and 96.95% (CI: 73.73%-141.59%), respectively. The 95% and 99% RCVs for CA724 were the highest, at 45.89 and 60.41, respectively. Conclusion: Our findings provide additional information regarding the biological variation of tumor markers, and could be applied in a clinical setting.
AB - Background: We sought to identify biological variations in the following tumor markers: pepsinogen I (PGI), pepsinogen II (PGII), carbohydrate antigen 724 (CA724), neuron-specific enolase (NSE), pro-gastrin-releasing peptide (ProGRP), carcinoembryonic antigen (CEA), and carbohydrate antigen 199 (CA199). Methods: Serum samples were collected from 20 healthy Chinese individuals over 5days. Samples were then screened for the presence of the seven aforementioned tumor markers. Within-individual coefficient of variation (CVI), between-individual coefficient of variation (CVG), confidence interval (CI) of biological variations, index of individuality (II), and the reference change value (RCV) of the seven tumor markers were calculated. Results: Of the 7 tumor markers, index of individuality was all <1.0. ProGRP showed the lowest CVI and CVG, at 4.75% (CI: 3.96%-5.94%) and 16.42% (CI: 12.32%-24.61%), respectively. The 95% and 99% RCVs for ProGRP were 14.68 and 19.32, respectively, and were the lowest of the markers. In contrast, the CVI and CVG for CA724 were the highest, at 16.06% (CI: 13.83%-19.17%) and 96.95% (CI: 73.73%-141.59%), respectively. The 95% and 99% RCVs for CA724 were the highest, at 45.89 and 60.41, respectively. Conclusion: Our findings provide additional information regarding the biological variation of tumor markers, and could be applied in a clinical setting.
KW - Biological variation
KW - Index of individuality
KW - Reference change value
KW - Tumor marker
UR - https://www.scopus.com/pages/publications/84941013176
U2 - 10.1016/j.cca.2015.08.026
DO - 10.1016/j.cca.2015.08.026
M3 - Article
C2 - 26327460
AN - SCOPUS:84941013176
SN - 0009-8981
VL - 450
SP - 233
EP - 236
JO - Clinica Chimica Acta
JF - Clinica Chimica Acta
ER -